文献速递白血病淋巴瘤

祖B-1 B细胞急性淋巴细胞白血病与3条关键通路的协同突变相关

Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways.
PubMed 文献 · Blood Adv · 2017-09-08

在NUP98-PHF23(NP23)转基因小鼠中发现一种新型B细胞白血病,其免疫表型为Lin- B220- CD19+ AA4.1+,与祖B-1细胞相同,VH基因使用偏向3' V区,基因表达谱最接近胎肝祖B细胞BC组分,支持其祖B-1起源。这些白血病获得Bcor和Janus激酶通路(Jak1/2/3和Stat5a)基因的自发突变,支持3条关键通路(干细胞自我更新、B细胞分化和细胞因子信号)协同诱导B细胞前体急性淋巴细胞白血病的假说。NP23祖B-1急性淋巴细胞白血病的基因表达谱比非CRLF2r急性淋巴细胞白血病更接近CRLF2r急性淋巴细胞白血病,且CRLF2r患者VH基因使用偏好与人B-1 B细胞所用VH区一致,提示该亚组患者可能起源于B-1而非B-2 B细胞。

要点

  • NP23转基因小鼠出现Lin- B220- CD19+ AA4.1+的祖B-1急性淋巴细胞白血病。
  • 该白血病获得Bcor和Jak通路(Jak1/2/3、Stat5a)基因自发突变。
  • NP23祖B-1白血病表达谱更接近CRLF2r急性淋巴细胞白血病,提示部分患者B-1起源。

核心结论

  • NP23转基因小鼠的祖B-1急性淋巴细胞白血病获得Bcor和Jak通路基因自发突变,支持3条关键通路协同诱导B细胞前体急性淋巴细胞白血病。
  • NP23祖B-1急性淋巴细胞白血病表达谱更接近CRLF2r急性淋巴细胞白血病,且CRLF2r患者VH使用偏好与人B-1 B细胞一致,提示该亚组患者可能为B-1而非B-2起源。

研究设计与样本

  • 研究使用NUP98-PHF23(NP23)转基因小鼠模型,发现一种新型B细胞白血病并进行免疫表型、VH基因使用和基因表达谱分析。
  • 对NP23祖B-1急性淋巴细胞白血病进行突变分析,并与患者CRLF2r急性淋巴细胞白血病基因表达谱和VH基因使用进行比较。

主要发现

  • NP23白血病免疫表型为Lin- B220- CD19+ AA4.1+,与祖B-1细胞相同,VH基因使用偏向3' V区,类似小鼠胎肝B细胞。
  • NP23白血病基因表达谱最接近胎肝祖B细胞BC组分,支持祖B-1起源。
  • NP23祖B-1急性淋巴细胞白血病获得Bcor和Janus激酶通路(Jak1/2/3和Stat5a)基因的自发突变。
  • NP23祖B-1急性淋巴细胞白血病基因表达谱比非CRLF2r急性淋巴细胞白血病更接近CRLF2r急性淋巴细胞白血病。
  • CRLF2r急性淋巴细胞白血病患者VH基因使用显示偏好使用人B-1 B细胞所用VH区。

关键数值与推荐

  • 原文未报告关键数值与推荐。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

B-1 and B-2 lymphocytes are derived from distinct developmental pathways and represent layered arms of the innate and adaptive immune systems, respectively. In contrast to a majority of murine B-cell malignancies, which stain positive with the B220 antibody, we discovered a novel form of B-cell leukemia in NUP98-PHF23 (NP23) transgenic mice. The immunophenotype (Lin- B220- CD19+ AA4.1+) was identical to that of progenitor (pro) B-1 cells, and VH gene usage was skewed toward 3' V regions, similar to murine fetal liver B cells. Moreover, the gene expression profile of these leukemias was most similar to that of fetal liver pro-B fraction BC, a known source of B-1 B cells, further supporting a pro-B-1 origin of these leukemias. The NP23 pro-B-1 acute lymphoblastic leukemias (ALLs) acquired spontaneous mutations in both Bcor and Janus kinase (Jak) pathway (Jak1/2/3 and Stat5a) genes, supporting a hypothesis that mutations in 3 critical pathways (stem-cell self-renewal, B-cell differentiation, and cytokine signaling) collaborate to induce B-cell precursor (BCP) ALL. Finally, the thymic stromal lymphopoietin (Tslp) cytokine is required for murine B-1 development, and chromosomal rearrangements resulting in overexpression of the TSLP receptor (CRLF2) are present in some patients with high-risk BCP-ALL (referred to as CRLF2r ALL). Gene expression profiles of NP23 pro-B-1 ALL were more similar to that of CRLF2r ALL than non-CRLF2r ALL, and analysis of VH gene usage from patients with CRLF2r ALL demonstrated preferential usage of VH regions used by human B-1 B cells, leading to the suggestion that this subset of patients with BCP-ALL has a malignancy of B-1, rather than B-2, B-cell origin.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Gough SM, Goldberg L, Pineda M, et al. Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways. Blood Adv. 2017. PMID: 29296821. doi:10.1182/bloodadvances.2017009837

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。